2026 ICD-10-CM Diagnosis Code H40.42X2Glaucoma secondary to eye inflammation, left eye, moderate stage

ICD-10-CM Codes›H00–H59›H40-H42›H40

ICD-10-CM H40.42X2
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

H40.42X2 is a billable ICD-10-CM diagnosis code for glaucoma secondary to eye inflammation, left eye, moderate stage. The 7th character 2 reports moderate stage glaucoma. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 124 through 125. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Glaucoma.

Code Identity

ICD-10-CM Code
H40.42X2
Billable Status
Yes — Valid for Submission
Code Describes
Glaucoma secondary to eye inflammation, left eye, moderate stage
Short Description
Glaucoma secondary to eye inflam, left eye, moderate stage
Parent Code
H40.42
Glaucoma secondary to eye inflammation, left eye

Code Classification

ChapterH00–H59Diseases of the eye and adnexa
SectionH40-H42Glaucoma
CategoryH40Glaucoma
This CodeH40.42X2Glaucoma secondary to eye inflammation, left eye, moderate stage

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR EYE003
Glaucoma
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Glaucoma

Glaucoma is a group of diseases that can damage the optic nerve of one, or both, of your eyes. This can result in vision loss. There are different types of glaucoma, but the most common type is open-angle glaucoma. Other less common types include angle-closure glaucoma, and congenital glaucoma.

The full article covers:

  • What is glaucoma?
  • What causes glaucoma?
  • What are the symptoms of glaucoma?
  • How is glaucoma diagnosed?
  • What are the treatments for glaucoma?
  • Can glaucoma be prevented?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert H40.42X2 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
365.62 Glaucoma w ocular inflam
Approximate The match is approximate rather than exact.
ICD-9-CM
365.62 Glaucoma w ocular inflam
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
365.72 Moderate stage glaucoma
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About H40.42X2Overview

Is H40.42X2 (Glaucoma secondary to eye inflammation, left eye) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report glaucoma secondary to eye inflammation, left eye, moderate stage on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character 2 in H40.42X2 mean?

The final character 2 reports moderate stage glaucoma, in this case involving the glaucoma secondary to eye inflammation.

What MS-DRG does H40.42X2 group to?

When glaucoma secondary to eye inflammation, left eye, moderate stage is the principal diagnosis on an inpatient stay, it groups to MS-DRG 124, 125, with relative weights from 0.7678 to 1.3231 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of H40.42X2?

Under the General Equivalence Mappings, glaucoma secondary to eye inflammation, left eye, moderate stage converts to ICD-9-CM 365.62 (glaucoma w ocular inflam), 365.62 (glaucoma w ocular inflam), and 365.72 (moderate stage glaucoma). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.